UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 430

Sortiert nach

Investment case for the prevention and reduction of childhood and adolescent overweight and obesity in Mexico

Obesity reviews, 2023-09, Vol.24 (9), p.e13595-n/a

2023

Volltextzugriff (PDF)

Population Pharmacokinetics and Exposure — Safety Analyses of Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Journal of clinical pharmacology, 2019-03, Vol.59 (3), p.364-373

2019

Volltextzugriff (PDF)

Decreased Surgical Site Infection Rate in Hysterectomy: Effect of a Gynecology-Specific Bundle

Obstetrics and gynecology (New York. 1953), 2018-06, Vol.131 (6), p.991-999

2018

Volltextzugriff (PDF)

Observed restrictive feeding practices among low‐income mothers of pre‐adolescents

Pediatric obesity, 2020-10, Vol.15 (10), p.e12666-n/a

2020

Volltextzugriff (PDF)

A behavior change communication intervention, but not livelihood interventions, improves diet diversity and animal-source food consumption among Ghanaian women

Food & nutrition research, 2022-07, Vol.66, p.1-12

2022

Volltextzugriff (PDF)

Population Pharmacokinetics and Exposure–Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial‐Onset Seizures

Journal of clinical pharmacology, 2018-07, Vol.58 (7), p.927-938

2018

Volltextzugriff (PDF)

Personal, behavioural and socio-environmental correlates of emerging adults’ sustainable food consumption in a cross-sectional analysis

Public health nutrition, 2023-06, Vol.26 (6), p.1306-1316

2023

Volltextzugriff (PDF)

Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations

The AAPS journal, 2014-09, Vol.16 (5), p.1009-1017

2014

Volltextzugriff (PDF)

Relationship of the Calcitonin Gene‐Related Peptide Monoclonal Antibody Galcanezumab Pharmacokinetics and Capsaicin‐Induced Dermal Blood Flow in Healthy Subjects

Clinical pharmacology in drug development, 2021-05, Vol.10 (5), p.440-452

2021

Volltextzugriff (PDF)

Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder

Journal of pharmacokinetics and pharmacodynamics, 2007-04, Vol.34 (2), p.183-206

2007

Volltextzugriff (PDF)

Reported organic food consumption and metabolic syndrome in older adults: cross-sectional and longitudinal analyses

European journal of nutrition, 2022-04, Vol.61 (3), p.1255-1271

2022

Volltextzugriff (PDF)

Changing sustainable diet behaviours during the COVID-19 Pandemic: inequitable outcomes across a sociodemographically diverse sample of adults

Journal of nutritional science (Cambridge), 2024-03, Vol.13, p.e16-e16, Article e16

2024

Volltextzugriff (PDF)

Correction to: Reported organic food consumption and metabolic syndrome in older adults: cross‑sectional and longitudinal analyses

European journal of nutrition, 2022-06, Vol.61 (4), p.2237-2237

2022

Volltextzugriff (PDF)

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy

Clinical pharmacology: advances and applications, 2017-01, Vol.9, p.65-72

2017

Volltextzugriff (PDF)

Population pharmacokinetic meta-analysis of trabectedin (ET-743, yondelis®) in cancer patients

Clinical pharmacokinetics, 2007-01, Vol.46 (10), p.867-884

2007

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacodynamics of Garenoxacin in Patients with Community-Acquired Respiratory Tract Infections

Antimicrobial Agents and Chemotherapy, 2004-12, Vol.48 (12), p.4766-4777

2004

Volltextzugriff (PDF)

94 Perinatal outcomes of asymptomatic versus symptomatic COVID positive pregnant women

American journal of obstetrics and gynecology, 2021-02, Vol.224 (2), p.S67-S67

2021

Volltextzugriff (PDF)

807 Oral nifedipine versus intravenous labetalol in the treatment of severe hypertension in the postpartum period

American journal of obstetrics and gynecology, 2021-02, Vol.224 (2), p.S502-S502

2021

Volltextzugriff (PDF)

Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics

Clinical pharmacology and therapeutics, 1993-10, Vol.54 (4), p.402-414

1993

Volltextzugriff (PDF)

Population pharmacokinetic modelling and simulation of fremanezumab in healthy subjects and patients with migraine

British journal of clinical pharmacology, 2019-12, Vol.85 (12), p.2721-2733

2019

Volltextzugriff (PDF)

Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses

Headache, 2020-07, Vol.60 (7), p.1376-1391

2020

Volltextzugriff (PDF)

Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites: Population Pharmacokinetic Modeling of Armodafinil

Journal of clinical pharmacology, 2017-02, Vol.57 (2), p.255-265

2017

Volltextzugriff (PDF)

Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures

Journal of pharmacokinetics and pharmacodynamics, 2018-08, Vol.45 (4), p.649-658

2018

Volltextzugriff (PDF)

Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites

Journal of clinical pharmacology, 2017-02, Vol.57 (2), p.255-265

2017

Volltextzugriff (PDF)

1 – 25 von 430

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(349)
Mit Volltextzugriff
(349)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(417)
Japanisch
(45)
Deutsch
(12)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Investment case for the prevention and reduction of childhood and adolescent overweight and obesity in Mexico

Population Pharmacokinetics and Exposure — Safety Analyses of Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Decreased Surgical Site Infection Rate in Hysterectomy: Effect of a Gynecology-Specific Bundle

Observed restrictive feeding practices among low‐income mothers of pre‐adolescents

A behavior change communication intervention, but not livelihood interventions, improves diet diversity and animal-source food consumption among Ghanaian women

Population Pharmacokinetics and Exposure–Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial‐Onset Seizures

Personal, behavioural and socio-environmental correlates of emerging adults’ sustainable food consumption in a cross-sectional analysis

Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations

Relationship of the Calcitonin Gene‐Related Peptide Monoclonal Antibody Galcanezumab Pharmacokinetics and Capsaicin‐Induced Dermal Blood Flow in Healthy Subjects

Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder

Reported organic food consumption and metabolic syndrome in older adults: cross-sectional and longitudinal analyses

Changing sustainable diet behaviours during the COVID-19 Pandemic: inequitable outcomes across a sociodemographically diverse sample of adults

Correction to: Reported organic food consumption and metabolic syndrome in older adults: cross‑sectional and longitudinal analyses

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy

Population pharmacokinetic meta-analysis of trabectedin (ET-743, yondelis®) in cancer patients

Population Pharmacokinetics and Pharmacodynamics of Garenoxacin in Patients with Community-Acquired Respiratory Tract Infections

Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City

94 Perinatal outcomes of asymptomatic versus symptomatic COVID positive pregnant women

807 Oral nifedipine versus intravenous labetalol in the treatment of severe hypertension in the postpartum period

Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics

Population pharmacokinetic modelling and simulation of fremanezumab in healthy subjects and patients with migraine

Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses

Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites: Population Pharmacokinetic Modeling of Armodafinil

Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures

Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites

Suchergebnisse filtern